Related Experiment Video

Updated: Aug 19, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

536

The role of noncoding RNAs in cancer lipid metabolism

Ye Wang1,2,3, Qian Li1,2,3, Song Wang1,2,3

  • 1Department of Gastrointestinal Surgery, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital of Wannan Medical College, Wuhu, Anhui, China.

Frontiers in Oncology
|December 1, 2022
PubMed

Insights

Noncoding RNAs (ncRNAs) influence tumor development by altering lipid metabolism enzymes. Targeting ncRNAs in lipid metabolism offers promising avenues for cancer prevention, detection, diagnosis, and treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Noncoding RNAs (ncRNAs), including microRNAs (miRNAs), cyclic RNAs (circRNAs), and long ncRNAs (lncRNAs), are crucial in regulating tumor cell proliferation, invasion, and migration.
  • Emerging evidence links ncRNAs to tumorigenesis and progression through modulation of lipid metabolism enzymes.

Purpose of the Study:

  • To review characterized ncRNAs involved in tumor lipid metabolism.
  • To highlight the significance of ncRNA-mediated lipid metabolism enzyme expression in malignant tumors and its impact on tumor development.

Main Methods:

  • Literature review of ncRNAs and tumor lipid metabolism mechanisms.
  • Analysis of ncRNA biological functions and lipid metabolic enzyme classifications.
  • Discussion of the role of ncRNAs in tumor lipid metabolism.

Main Results:

  • ncRNAs play a significant role in regulating lipid metabolism within tumor cells.
  • Dysregulation of lipid metabolism by ncRNAs contributes to cancer progression.
  • ncRNAs offer potential as biomarkers and therapeutic targets in oncology.

Conclusions:

  • ncRNAs are critical regulators of tumor lipid metabolism, impacting cancer development.
  • Future research should explore ncRNAs for disease prevention, detection, diagnosis, and treatment.
  • ncRNA-targeted therapies represent a promising future direction in cancer medicine.
Keywords:
diagnosislipid metabolismnoncoding RNAtreatmenttumor

More Related Videos

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

605
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

2.5K

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.5K
Types of RNA01:20

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
6.0K